Loading clinical trials...
Loading clinical trials...
Role of Hyperinsulinemia in Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis: Pancreatic Clamp Pilot & Feasibility Study
Conditions
Interventions
Insulin human
Octreotide Acetate
+8 more
Locations
1
United States
Columbia University Irving Medical Center
New York, New York, United States
Start Date
August 29, 2023
Primary Completion Date
September 24, 2025
Completion Date
September 24, 2025
Last Updated
January 12, 2026
NCT07403604
NCT07286747
NCT00001987
NCT07483723
NCT07460856
NCT07440147
Lead Sponsor
Columbia University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions